Ryvyl Inc. (RVYL) Dividend History

Ryvyl Inc. (RVYL) is a biotechnology company focused on advancing regenerative medicine and tissue engineering technologies. The company develops innovative solutions to improve tissue repair and wound healing, aiming to address unmet medical needs in healthcare.

3131 Camino Del Rio North, Suite 1400, San Diego, CA, 92108
Phone: 619-631-8261
Website:

Dividend History

Ryvyl Inc. currently does not pay dividends

Company News

  • RYVYL Inc. announced the conversion of its remaining 8% Senior Convertible Note into 7.1 million shares of common stock, completing its balance sheet restructuring process.

    GlobeNewswire Inc.
  • RYVYL Inc. has ceased discussions to restructure the terms of the pre-funded asset sale of its RYVYL EU subsidiary. The company expects the buyer will now take the final steps to close the pre-funded asset sale.

    GlobeNewswire Inc.
  • Johnson Fistel, LLP is conducting an investigation into potential securities law violations by certain officers at Inari Medical, Hertz Global, Fastly, and Ryvyl. The firm is considering initiating derivative lawsuits on behalf of long-term investors in these companies.

    GlobeNewswire Inc.
    Featured Companies: FSLY HTZ
  • -Fintech veteran Christian Murray, who will lead RYVYL’s licensing strategy, expands role from VP of Revenue to newly created position of Managing Director, Northeast Merchant Systems -

    GlobeNewswire Inc.
  • Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. Skillsoft posted adjusted loss of $3.09 per share, versus market estimates of $3.27 per share. The company’s quarterly sales came in at $137.540 million versus expectations of $141.897 million. Skillsoft shares dipped 26.7% to $6.74 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers WiSA Technologies, Inc. (NASDAQ: WISA) jumped 85% to $3.2379 after the company announced a 5-year WiSA E licensing agreement with an HDTV/PTV brand. Palisade Bio, Inc. (NASDAQ: PALI) shares climbed 79.1% to $7.45 after the company announced the completion of analysis evaluating ex-vivo bioactivation of PALI-2108. Jaguar Health, Inc. (NASDAQ: JAGX) shares gained 67% to $0.1989 after the company signed an exclusive 5-year in-license agreement with Venture Life Group for Gelclair. Dynatronics Corporation (NASDAQ: DYNT) shares rose 44.4% to $0.5342 after dipping over 5% on Monday. IMAC Holdings, Inc. (NASDAQ: BACK) surged 40% to $4.69. Peraso Inc. (NASDAQ: PRSO) gained 38.8% to $1.75. Peraso recently announced that it received an additional $2.88 million purchase order. Macatawa Bank Corporation (NASDAQ: MCBC) rose 38.8% to $13.78 after Wintrust Financial Corporation (NASDAQ: WFTC) and Macatawa Bank announced that they have entered into a definitive merger agreement for Wintrust to acquire Macatawa in an all-stock transaction. China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) jumped 29.9% to ...

    Benzinga
Dividend data last updated 06/07/2025 14:50:57 UTC